Bright Minds Biosciences (NASDAQ: DRUG) successfully closed a public offering of 1.945 million common shares at US$90 per share, raising US$175.05 million in gross proceeds. The company plans to use the net proceeds to fund clinical trials for drug candidates targeting absence seizures, DEE, Prader-Willi Syndrome, and BMB-105, along with R&D and general corporate purposes.

Bright Minds Biosciences priced an upsized public offering of 1,945,000 common shares at $90 per share for gross proceeds of $175.05 million. The company plans to use net proceeds to fund clinical trials for drug candidates targeting absence seizures, DEE, and Prader-Willi Syndrome, as well as phase 1 trials for BMB-105. The offering is expected to close on January 9, 2026.

Bright Minds Biosciences strengthened its scientific advisory board with four experts in Prader-Willi Syndrome, launching a new investigational drug program targeting the rare genetic disorder. The company will evaluate existing and new treatment candidates, with initial Phase 1 studies focusing on safety and tolerability.

Bright Minds Biosciences will present at the Guggenheim Healthcare Innovation Conference and Jefferies Global Healthcare Conference in November 2025, and has granted stock options to directors, officers, and consultants.

Firefly Neuroscience, a Nasdaq-listed AI company, announced its Q3 2024 financial results and provided updates on its partnerships with pharmaceutical companies like Bright Minds Bioscience, Novartis, and Takeda to advance its Brain Network Analytics (BNA) technology for neurological and mental disorder treatments.

Bright Minds Biosciences Inc. has closed a $35 million private placement, with participation from several healthcare investors. The company plans to use the proceeds for research and development related to its drug development programs.

Bright Minds Biosciences announced the initiation of a Phase 2 clinical trial of BMB-101, a novel 5-HT2C agonist, for the treatment of drug-resistant epilepsies. The company will host a KOL event to discuss the trial and the unmet needs in epilepsy care.

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Decibel Therapeutics, Inc. (NASDAQ: DBTX) gained 76% to $4.9150 after Regeneron announced it will acquire the company. Benitec Biopharma Inc. (NASDAQ: BNTC) jumped 75.8% to $3.3937. Benitec Biopharma reported pricing of $30 million underwritten public offering. Renovaro Biosciences Inc. (NASDAQ: RENB) shares gained 68.2% to $1.43 after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge. T Stamp Inc. (NASDAQ: IDAI) climbed 48.8% to $2.3518. EBET, Inc. (NASDAQ: EBET) surged 40.5% to $0.0405 on abnormally-high volume. The stock was set to be suspended at the opening of business today unless the company requested an appeal of Nasdaq's Listing Qualifications Department's determination. Millennium Group International Holdings Limited (NASDAQ: MGIH) gained 40% to $2.7003 on strong volume. Science 37 Holdings, Inc. (NASDAQ: SNCE) jumped 39.3% to $0.3765 following better-than-expected quarterly results. BioNexus Gene Lab Corp. (NASDAQ: BGLC) gained 36.5% to $1.5699. Kubient, Inc. (NASDAQ: KBNT) rose 33.7% to $0.63. Oportun Financial Corporation (NASDAQ: OPRT) gained 31.3% to $6.90 following strong quarterly results. Poseida Therapeutics, Inc. (NASDAQ: PSTX) climbed 31.3% to $2.60 following quarterly results. Mirati Therapeutics, Inc. (NASDAQ: MRTX) surged 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target. Allbirds, Inc. (NASDAQ: BIRD) gained 29% to $1.65 after the company reported better-than-expected second-quarter financial results. Array Technologies, Inc. (NASDAQ: ARRY) climbed 27.8% to $22.85 following a second-quarter earnings beat. Computer Task Group, Incorporated (NASDAQ: CTG) gained 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share. LivePerson, Inc. (NASDAQ: LPSN) rose 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO. PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) gained 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results. Celsius Holdings, Inc. (NASDAQ: CELH) jumped 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results. United Insurance Holdings Corp. (NASDAQ: UIHC) gained 21.3% to $6.83. DMC Global Inc. (NASDAQ: BOOM) climbed 19.8% to $21.03 following quarterly results. Dutch Bros Inc. (NYSE: BROS) surged 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance. Azenta, Inc. (NASDAQ: AZTA) gained 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock. ThredUp Inc. (NASDAQ: TDUP) climbed 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock. Planet Green Holdings Corp. (NASDAQ: PLAG) rose 17.5% to $0.5670. Anavex Life Sciences Corp. (NASDAQ: AVXL) climbed 16.2% to $ 9.33. Rapid7, ...

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Tuesday. The Dow traded down 0.64% to 35,246.87 while the NASDAQ fell 0.98% to 13,857.43. The S&P 500, also fell, dropping, 0.65% to 4,489.12. Check This Out: Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month   Leading and Lagging Sectors Health care shares jumped by 0.3% on Tuesday. In trading on Tuesday, financial shares fell 1.3%.   Top Headline United Parcel Service Inc (NYSE: UPS) reported mixed second-quarter financial results and issued FY23 revenue guidance below estimates. United Parcel Service reported a second-quarter FY23 revenue decline of 10.9% year-over-year to $22.055 billion, missing the consensus of $23.11 billion. Adjusted EPS was $2.54, compared to $3.29, beating the consensus of $2.50. For FY23, UPS now expects consolidated revenue to be about $93 billion (prior $97 billion) Vs. consensus of $96.77 billion and an adjusted operating margin of around 11.8% (prior 12.8%).   Equities Trading UP Nuburu, Inc. (NYSE: BURU) shares shot up 38% to $14.31 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology. Shares of Paymentus Holdings, Inc. (NYSE: PAY) got a boost, shooting 34% to $14.31 after the company reported better-than-expected second-quarter financial results. Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares were also up, gaining 36% to $4.37 after the company disclosed data for BMB-101.   Equities Trading ...

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology. Vivos Therapeutics, Inc. (NASDAQ: VVOS) gained 91.1% to $0.4987 after falling more than 10% on Monday. Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 87.6% to $6.04 after the company disclosed data for BMB-101. Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares jumped 63.9% to $0.1472 after falling over 25% on Monday. The company recently announced its plans to reduce the company's headcount by 78%. Gorilla Technology Group Inc. (NASDAQ: GRRR) rose 32.2% to $2.04 as the company hired Global Economics Group for due diligence, advancing in battle against illegal short selling. Paymentus Holdings, Inc. (NYSE: PAY) shares gained 29.4% to $13.76 after reporting better-than-expected quarterly results. Bionomics Limited (NASDAQ: BNOX) jumped 24% to $1.60. Kyndryl Holdings, Inc. (NYSE: KD) gained 23% to $15.32 after the company raised its FY24 earnings outlook and said it expects its fiscal 2024 adjusted free cash flow will be positive. ePlus inc. (NASDAQ: PLUS) rose 20.8% to $69.99 following better-than-expected quarterly results. Quanterix Corporation (NASDAQ: QTRX) gained 20.4% to $26.17 after reporting upbeat quarterly results. Sterling Infrastructure, Inc. (NASDAQ: STRL) surged 19.9% to $74.12 after reporting upbeat quarterly results. CECO Environmental Corp. (NASDAQ: CECO) rose 19.3% to $14.01 after the company posted upbeat quarterly sales and increased FY23 revenue guidance. Tilray Brands, Inc. (NASDAQ: TLRY) climbed 19% to $2.6484 after the Canadian cannabis and packaged goods company announced a deal to acquire eight beer brands from Anheuser-Busch Inbev. Viant Technology Inc. (NASDAQ: DSP) gained 18.2% to $5.42 following strong quarterly results. Latham Group, Inc. (NASDAQ: SWIM) gained 18.1% to $4.50 following strong quarterly sales. WW International, Inc. (NASDAQ: WW) jumped 18.1% to $9.45. MannKind Corporation (NASDAQ: MNKD) rose 17.7% to $5.41 following strong quarterly results. Novo Nordisk A/S (NYSE: NVO) climbed 17.4% to $189.48 after the company announced headline results from the SELECT cardiovascular outcomes trial showing Semaglutide 2.4 mg reduced risk of major adverse cardiovascular events by 20%. Eli Lilly and Company (NYSE: LLY) rose 16.6% to $529.61 after the company raised its FY23 guidance. The company also reported better-than-expected second-quarter earnings, including strong Mounjaro sales growth. DocGo Inc. (NASDAQ: DCGO) gained 16.3% to $10.59 following upbeat sales. United States Cellular Corporation (NYSE: USM) jumped 15.2% to $36.00. JP Morgan upgraded United States Cellular from Neutral to Overweight. AdaptHealth Corp. (NASDAQ:

U.S. stocks were lower midway through trading, with the Dow Jones falling over 1% on Tuesday. The Dow traded down 1.05% to 35,099.88 while the NASDAQ fell 1.47% to 13,788.21. The S&P 500, also fell, dropping, 1.09% to 4,469.36. Check This Out: Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month   Leading and Lagging Sectors Health care shares jumped by 0.5% on Tuesday. In trading on Tuesday, financial shares fell 1.8%.   Top Headline Eli Lilly and Company (NYSE: LLY) reported upbeat second-quarter results and raised its annual guidance. Eli Lilly reported sales of $$8.31 billion, up 28% Y/Y, beating the consensus of $7.58 billion. Eli Lilly posted an adjusted EPS of $2.11, beating the consensus of $1.99. The company also raised its annual revenue forecast to $33.4-$33.9 billion from prior guidance of $31.2-$31.7 billion versus the consensus of $31.44 billion. The company sees adjusted EPS Of $9.70-$9.90 from prior guidance of $8.65-$8.85 compared to the consensus of $8.71.   Equities Trading UP Nuburu, Inc. (NYSE: BURU) shares shot up 79% to $1.0387 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology. Shares of Paymentus Holdings, Inc. (NYSE: PAY) got a boost, shooting 28% to $13.68 after the company reported better-than-expected second-quarter financial results. Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares were also up, gaining 42% to $4.58 after the company disclosed data for BMB-101.   Equities Trading ...

U.S. stocks were lower this morning, with the Nasdaq Composite falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.82% to 35,182.19 while the NASDAQ fell 0.81% to 13,880.85. The S&P 500, also fell, dropping, 0.72% to 4,486.06. Check This Out: Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month   Leading and Lagging Sectors Health care shares jumped by 0.7% on Tuesday. In trading on Tuesday, energy shares fell 2%.   Top Headline The U.S. trade deficit shrank to a three-month low level of $65.5 billion in June versus a revised $68.3 billion in May. Exports from the U.S. fell by $0.3 billion to $247.5 billion in June, while imports fell by $3.1 billion to $313.0 billion.   Equities Trading UP Nuburu, Inc. (NYSE: BURU) shares shot up 215% to $1.83 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology. Shares of Vivos Therapeutics, Inc. (NASDAQ: VVOS) got a boost, shooting 74% to $0.4539 after falling more than 10% on Monday. Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares were also up, gaining 95% to $6.33 after the company disclosed data for BMB-101.   Equities Trading DOWN Proterra Inc. (NASDAQ: PTRA) shares dropped 76% to $0.3470 after the company announced it ...